MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 125 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $32,000 | -62.8% | 25,828 | -3.9% | 0.00% | -100.0% |
Q1 2017 | $86,000 | -17.3% | 26,878 | +3.0% | 0.00% | 0.0% |
Q4 2016 | $104,000 | -37.0% | 26,103 | -5.8% | 0.00% | -50.0% |
Q3 2016 | $165,000 | +10.7% | 27,703 | +6.1% | 0.00% | +100.0% |
Q2 2016 | $149,000 | -61.9% | 26,103 | -44.7% | 0.00% | 0.0% |
Q1 2016 | $391,000 | +15.7% | 47,206 | +9.3% | 0.00% | 0.0% |
Q4 2015 | $338,000 | +46.3% | 43,206 | +78.5% | 0.00% | 0.0% |
Q3 2015 | $231,000 | -13.8% | 24,203 | +10.6% | 0.00% | 0.0% |
Q2 2015 | $268,000 | +24.7% | 21,881 | +22.8% | 0.00% | 0.0% |
Q1 2015 | $215,000 | +19.4% | 17,825 | +11.8% | 0.00% | 0.0% |
Q4 2014 | $180,000 | +11.8% | 15,944 | -16.3% | 0.00% | 0.0% |
Q3 2014 | $161,000 | +14.2% | 19,049 | -1.2% | 0.00% | 0.0% |
Q2 2014 | $141,000 | +5.2% | 19,276 | -27.7% | 0.00% | 0.0% |
Q1 2014 | $134,000 | +7.2% | 26,660 | +13.9% | 0.00% | 0.0% |
Q4 2013 | $125,000 | +66.7% | 23,410 | +8.1% | 0.00% | – |
Q3 2013 | $75,000 | -51.0% | 21,660 | -4.5% | 0.00% | -100.0% |
Q2 2013 | $153,000 | – | 22,690 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |